Publicité
Publicité

BFRI

BFRI logo

Biofrontera Inc. Common Stock

0.82
USD
Sponsorisé
0.00
-0.60%
09 janv., 15:34 UTC -5
Fermé
exchange

Après-marché

0.81

-0.01
-0.61%

BFRI Rapports sur les bénéfices

Ratio de surprise positive

BFRI a dépassé 4 des 17 dernières estimations.

24%

Prochain rapport

Date du prochain rapport
19 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
$15.85M
/
$0.15
Variation implicite de Q3 25 (Revenue/ EPS)
+126.79%
/
-124.19%
Variation implicite de Q4 24 (Revenue/ EPS)
+26.19%
/
-160.00%

Biofrontera Inc. Common Stock earnings per share and revenue

On 12 nov. 2025, BFRI reported earnings of -0.62 USD per share (EPS) for Q3 25, missing the estimate of -0.59 USD, resulting in a -4.80% surprise. Revenue reached 6.99 million, compared to an expected 7.14 million, with a -2.13% difference. The market reacted with a -8.59% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analystes forecast an EPS of 0.15 USD, with revenue projected to reach 15.85 million USD, implying an baisse of -124.19% EPS, and hausse of 126.79% in Revenue from the last quarter.
FAQ
For Q3 2025, Biofrontera Inc. Common Stock reported EPS of -$0.62, missing estimates by -4.8%, and revenue of $6.99M, -2.13% below expectations.
The stock price moved down -8.59%, changed from $0.97 before the earnings release to $0.89 the day after.
The next earning report is scheduled for 19 mars 2026.
Based on 4 analystes, Biofrontera Inc. Common Stock is expected to report EPS of $0.15 and revenue of $15.85M for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité